Management

All people with TRPM3related conditions should have a full neurological and developmental evaluation. This usually includes cognitive testing, an EEG (ideally with sleep recording to look for special seizure patterns), and a brain MRI. These tests help doctors understand how the brain is working and whether any structural changes are present. If a patient has a TRPM3variant that has never been reported before, researchers may perform lab studies to see how the gene change affects the TRPM3 channel and how it responds to medications like primidone.

Because TRPM3 related disorders are caused by an overactive TRPM3 channel, treatments that calm the channel can help. Primidone, an FDA approved medication, blocks TRPM3 and is currently the only targeted treatment available. Many patients on primidone become seizure free and show progress in learning and development. Starting primidone early—even before seizures begin—may be beneficial for confirmed gain of function variants. However, primidone may work less well if the patient’s TRPM3mutation affects the drug’s binding site.

Children also benefit from early therapies to support motor, speech, and learning skills. For those with limited speech, sign language or picture-based communication can be helpful. Behavioural support may be needed for autism related traits, aggression, or sleep problems. Regular checkups with orthopedic specialists (for hips, spine, and feet) and eye doctors (for vision problems) are recommended.

Support group: TRPM3 Foundation – www.trpm3.org